Rights and permissions
About this article
Cite this article
Gavilimomab not superior to antithymocyte globulin in steroid-resistant graft-versus-host disease. Inpharma Wkly. 1376, 8 (2003). https://doi.org/10.2165/00128413-200313760-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313760-00016